2026 NPPES data Anatomic Pathology Physician NPI 1114984820 M.D., MPH, FCAP
Verify on CMS →

MANLIO LOCONTE, M.D., MPH, FCAP

Anatomic Pathology Physician in BOSTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
311
Medicare Part D claims · 33 beneficiaries · Anatomic Pathology Physician avg: 214
Generic prescribing
71%
generic claims · 29% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$41.6K
12 payments · CMS Open Payments (Sunshine Act)
What the federal data reveals: MANLIO LOCONTE, M.D., MPH, FCAP is a Anatomic Pathology Physician ([object Object]) practicing in BOSTON, Massachusetts with a Medicare Part D prescribing footprint of 311 claims across 33 beneficiaries — 29% brand-name prescribing . Industry payments of $41.6K across 12 transactions are disclosed under CMS Open Payments (Sunshine Act).

What stands out: MANLIO LOCONTE, M.D., MPH, FCAP filed 311 Medicare Part D claims in 2023 across BOSTON, Massachusetts. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

MANLIO LOCONTE, M.D., MPH, FCAP practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

MANLIO LOCONTE, M.D., MPH, FCAP at a glance

Quality data not reported

NPI registry status

Active

Issued 04/27/2006

NPI 1114984820

Primary specialty

Anatomic Pathology Physician

Niche

2,597 US NPIs in this specialty

Medicare Part D claims

311 45% vs specialty avg

2023 prescription claims

Specialty avg: 214

Specialty distribution in Massachusetts

How Anatomic Pathology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Anatomic Pathology Physician share within Massachusetts

1. Anatomic Pathology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Anatomic Pathology Physician share within Massachusetts

Specialty board-certification context

Estimated specialty board-certified rate — Anatomic Pathology Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Anatomic Pathology Physician ABMS/AOA estimate

Est. board-certified rate (Anatomic Pathology Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Anatomic Pathology Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MANLIO LOCONTE, M.D., MPH, FCAP is a Anatomic Pathology Physician provider practicing in BOSTON, Massachusetts, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D., MPH, FCAP. NPI: 1114984820. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MANLIO LOCONTE, M.D., MPH, FCAP appears in the CMS NPPES registry as a Anatomic Pathology Physician provider holding M.D., MPH, FCAP credentials at 800 WASHINGTON STREET BOX 1013, BOSTON, MA, 02111, with a listed phone of (617) 636-5000. NPI 1114984820 was issued on 04/27/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what LOCONTE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 311 prescription claims written by this provider, covering 33 Medicare beneficiaries and totaling roughly $65K in drug spend, split 29% brand-name and 71% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Anatomic Pathology Physician is a narrow specialty nationwide, with 2,597 enrolled providers across 54 states and an average of 214 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

800 WASHINGTON STREET BOX 1013
BOSTON, MA 02111

Provider Details

NPI 1114984820
Specialty Anatomic Pathology Physician
Credentials M.D., MPH, FCAP
Gender Male
NPI Issued 04/27/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for MANLIO LOCONTE, M.D., MPH, FCAP. Source: openpaymentsdata.cms.gov.

Total received

$41.6K

Largest payer

Takeda Pharmaceuticals U.S.A., Inc.

Most common payment type

Consulting Fee

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MANLIO LOCONTE, M.D., MPH, FCAP. To verify MANLIO LOCONTE, M.D., MPH, FCAP's current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MANLIO LOCONTE, M.D., MPH, FCAP — brand share 29.0%
Specialty average (est.)

29% brand-name claims vs 71% generic, on 311 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

311
Total Claims
$65K
Total Drug Cost
33
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
311
Total Day Supply
6,410
Brand vs Generic
29% brand / 71% generic
Brand Drug Cost
$41K
Generic Drug Cost
$24K

Patient Demographics

Average Patient Age
58.0 years
Avg HCC Risk Score
1.46
Gender Split
39% female / 61% male
Age Distribution
<65: 21, 65-74: N/A, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Buprenorphine-Naloxone
Buprenorphine Hcl/Naloxone Hcl
218
Suboxone
Buprenorphine Hcl/Naloxone Hcl
89

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Anatomic Pathology Physician Overview

How MANLIO LOCONTE, M.D., MPH, FCAP fits within the Anatomic Pathology Physician landscape nationally.

2,597
Anatomic Pathology Physician Providers in US
54
States with Anatomic Pathology Physician
214
Avg Claims per Provider

MANLIO LOCONTE, M.D., MPH, FCAP's 311 claims are above the specialty average of 214.

Nearby Anatomic Pathology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as LOCONTE.

Compare Anatomic Pathology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MANLIO LOCONTE, M.D., MPH, FCAP's specialty?
MANLIO LOCONTE, M.D., MPH, FCAP specializes in Anatomic Pathology Physician and practices in BOSTON, Massachusetts. Credentials: M.D., MPH, FCAP.
How much does MANLIO LOCONTE, M.D., MPH, FCAP prescribe under Medicare Part D?
In 2023, MANLIO LOCONTE, M.D., MPH, FCAP wrote 311 Medicare Part D claims totaling $65K in drug costs for 33 beneficiaries.
Where is MANLIO LOCONTE, M.D., MPH, FCAP located?
MANLIO LOCONTE, M.D., MPH, FCAP is located at 800 WASHINGTON STREET BOX 1013, BOSTON, MA, 02111. Phone: (617) 636-5000.
What is MANLIO LOCONTE, M.D., MPH, FCAP's NPI number?
MANLIO LOCONTE, M.D., MPH, FCAP's National Provider Identifier (NPI) is 1114984820, issued on 04/27/2006.
Does MANLIO LOCONTE, M.D., MPH, FCAP prescribe more brand-name or generic drugs?
MANLIO LOCONTE, M.D., MPH, FCAP's prescribing is 29% brand-name and 71% generic drugs by claim count, with $41K in brand drug costs.
How many Anatomic Pathology Physician providers are there in the US?
There are 2,597 Anatomic Pathology Physician providers across 54 states in the US. The average Anatomic Pathology Physician provider writes 214 Medicare Part D claims per year.
What drugs does MANLIO LOCONTE, M.D., MPH, FCAP prescribe most often?
Based on 2023 Medicare Part D data, MANLIO LOCONTE, M.D., MPH, FCAP's most frequently prescribed drugs include Buprenorphine-Naloxone, Suboxone. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MANLIO LOCONTE, M.D., MPH, FCAP accept Medicare?
MANLIO LOCONTE, M.D., MPH, FCAP appears in CMS Medicare data with 311 Part D claims and 33 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MANLIO LOCONTE, M.D., MPH, FCAP's credentials?
MANLIO LOCONTE, M.D., MPH, FCAP's NPI is 1114984820 with credentials M.D., MPH, FCAP. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology